Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E

Carcinogenesis

Volumn 27, Issue 7, 2006, Pages 1358-1368

  Chen, Connie S ^a   Wells, Peter G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER RISK; CARCINOGENESIS; CELL SPECIFICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DNA DEGRADATION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG MEGADOSE; EMBRYO; FEMALE; FETOTOXICITY; FETUS DEATH; GENE LOCATION; GENETIC CODE; GENOTYPE; GESTATIONAL AGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PROTEIN DEFICIENCY; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; FEMALE; GENOTYPE; MALE; MICE; MICE, KNOCKOUT; NEOPLASMS; OXIDATION-REDUCTION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN E;

EID: 33745598549     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi325     Document Type: Article

References (94)

1. Ames,B.N. (2001) DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res., 475, 7-20.
2. Williams,G.M. and Jeffrey,A.M. (2000) Oxidative DNA damage: Endogenous and chemically induced. Regul. Toxicol. Pharmacol., 32, 283-292.
3. Wells,P.G. and Winn,L.M. (1996) Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. Biol., 31, 1-40.
4. Wells,P.G., Bhuller,Y., Chen,C.S., Jeng,W., Kasapinovic,S., Kennedy,J.C., Kim,P.M., Laposa,R.R., McCallum,G.P., Nicol,C.J., Parman,T., Wiley,M.J. and Wong,A.W. (2005) Molecular and biochemical mechanism in teratogenesis involving reactive oxygen species. Toxicol. Appl. Pharmacol., 207(2S), 348-359.
5. Halliwell,B. (2001) Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs Aging, 18, 685-716.
6. Mates,J.M., Perez-Gomez,C. and Nunez de Castro,I. (1999) Antioxidant enzymes and human diseases. Clin. Biochem., 32, 595-603.
7. Esposito,F., Ammendola,R., Faraonio,R., Russo,T. and Cimino,F. (2004) Redox control of signal transduction, gene expression and cellular senescence. Neurochem. Res., 29, 617-28.
8. Martin,K.R. and Barrett,J.C. (2002) Reactive oxygen species as double-edged swords in cellular processes: Low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol., 21, 71-5.
9. Imlay,J.A. (2003) Pathways of oxidative damage. Annu. Rev. Microbiol., 57, 395-418.
10. Floyd,R.A. (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis, 11, 1447-1450.
11. Kuchino,Y., Mori,F., Kasai,H., Inoue,H., Iwai,S., Miura,K., Ohtsuka,E. and Nishimura,S. (1987) Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature, 327, 77-79.
12. Woods,J.R.,Jr, Plessinger,M.A. and Miller,R.K. (2001) Vitamins C and E: missing links in preventing preterm premature rupture of membranes?. Am. J. Obstet. Gynecol., 185, 5-10.
13. Khan,J.Y. and Black,S.M. (2003) Developmental changes in murine brain antioxidant enzymes. Pediat. Res., 54, 77-82.
14. Winn,L.M. and Wells,P.G. (1999) Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Radic. Biol. Med., 26, 266-274.
15. el-Hage,S. and Singh,S.M. (1990) Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev. Genet., 11, 149-159.
16. Serafini,M.T., Arola,L. and Romeu,A. (1991) Glutathione and related enzyme activity in the 11-day rat embryo, placenta and perinatal rat liver. Biol. Neonate, 60, 236-242.
17. Nicol,C.J., Zielenski,J., Tsui,L.C. and Wells,P.G. (2000) An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J., 14, 111-127.
18. Anderson,L.M. (2004) Introduction and overview. Perinatal carcinogenesis: Growing a node for epidemiology, risk management, and animal studies. Toxicol. Appl. Pharmacol., 199, 85-90.
19. Ahlgren,M., Melbye,M., Wohlfahrt,J. and Sorensen,T.I. (2004) Growth patterns and the risk of breast cancer in women. N. Engl. J. Med., 351, 1619-1626.
20. Donehower,L.A., Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery,C.A.,Jr, Butel,J.S. and Bradley,A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
21. Jacks,T., Remington,L., Williams,B.O., Schmitt,E.M., Halachmi,S., Bronson,R.T. and Weinberg,R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
22. Nicol,C.J., Harrison,M.L., Laposa,R.R., Gimelshtein,I.L. and Wells,P.G. (1995) A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet., 10, 181-187.
23. Wong,A. and Wells,P.G. (2002) p53 modulation of phenyotoin embryopathies in p53 knockout mice. Toxicol. Sci. (Suppl.: The Toxicologist), 66, 306-307, (No. 1502, Abstract).
24. Siman,C.M. and Eriksson,U.J. (1997) Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes, 46, 1054-1061.
25. Sanyal,S. and Wells,PG (1993) Reduction in phenytoin teratogenicity by pretreatment with the antioxidant d-alpha-tocopherol acetate (vitamin E) in CD-1 mice. Toxicologist, 13, 252, Abstract.
26. Sawant,S.S. and Kandarkar,S.V. (2000) Role of vitamins C and E as chemopreventive agents in the hamster cheek pouch treated with the oral carcinogen-DMBA. Oral. Dis., 6, 241-247.
27. Klaunig,J.E. and Kamendulis,L.M. (1999) Mechanisms of cancer chemo-prevention in hepatic carcinogenesis: Modulation of focal lesion growth in mice. Toxicol. Sci., 52, 101-106.
28. Prasad,K.N. and Edwards-Prasad,J. (1992) Vitamin E and cancer prevention: Recent advances and future potentials. J. Am. Coll. Nutr., 11, 487-500.
29. Dusinska,M., Kazimirova,A., Barancokova,M., Beno,M., Smolkova,B., Horska,A., Raslova,K., Wsolova,L. and Collins,A.R. (2003) Nutritional supplementation with antioxidants decreases chromosomal damage in humans. Mutagenesis, 18, 371-376.
30. Patterson,R.E., White,E., Kristal,A.R., Neuhouser,M.L. and Potter,J.D. (1997) Vitamin supplements and cancer risk: The epidemiologic evidence. Cancer Causes Control, 8, 786-802.
31. Dutta,A. and Dutta,S.K. (2003) Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: A review. J. Am. Coll. Nutr., 22, 258-268.
32. Ricciarelli,R., Zingg,J.M. and Azzi,A. (2001) Vitamin E: Protective role of a Janus molecule. FASEB J., 15, 2314-2325.
33. Virtamo,J., Pietinen,P., Huttunen,J.K., Korhonen,P., Malila,N., Virtanen,M.J., Albanes,D., Taylor,P.R. and Albert,P. (2003) Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up. JAMA, 290, 476-485.
34. Schwartz,J.L. (1996) The dual roles of nutrients as antioxidants and prooxidants: Their effects on tumor cell growth. J. Nutr., 126, 1221S-1227S.
35. Ricciarelli,R., Zingg,J.M. and Azzi,A. (2002) The 80th anniversary of vitamin E: Beyond its antioxidant properties. Biol. Chem., 383, 457-465.
36. Brigelius-Flohe,R., Kelly,F.J., Salonen,J.T., Neuzil,J., Zingg,J.M. and Azzi,A. (2002) The European perspective on vitamin E: Current knowledge and future research. Am. J. Clin. Nutr., 76, 703-716.
37. Prasad,K.N., Edwards-Prasad,J., Kumar,S. and Meyers,A. (1993) Vitamins regulate gene expression and induce differentiation and growth inhibition in cancer cells. Their relevance in cancer prevention. Arch. Otolaryngol. Head Neck Surg., 119, 1133-1140.
38. Azzi,A. (2004) The role of alpha-tocopherol in preventing disease. Eur. J. Nutr., 43 (Suppl. 1), I18-I25.
39. Chen,C.S. and Wells,P.G. (2001) Effect of dietary vitamin E on endogenous and phenytoin-initiated embryonic DNA oxidation. Toxicol. Sci. (Suppl.: The Toxicologist), 60, 48, (No. 234, Abstract).
40. Gupta,R.C. and Dighe,N.R. (1984) Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene. Carcinogenesis, 5, 343-349.
41. Parman,T., Chen,G. and Wells,P.G. (1998) Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis. J. Biol. Chem., 273, 25079-25088.
42. Cooke,M.S., Evans,M.D., Dizdaroglu,M. and Lunec,J. (2003) Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J., 17, 1195-1214.
43. Loft,S. and Poulsen,H.E. (1996) Cancer risk and oxidative DNA damage in man. J. Mol. Med., 74, 297-312.
44. Wang,D., Kreutzer,D.A. and Essigmann,J.M. (1998) Mutagenicity and repair of oxidative DNA damage: Insights from studies using defined lesions. Mutat Res., 400, 99-115.
45. Hiraoka,M. (2001) Nutritional status of vitamin A, E, C, B1, B2, B6, nicotinic acid, B12, folate, and beta-carotene in young women. J. Nutr. Sci. Vitaminol. (Tokyo), 47, 20-27.
46. Traber,M.G. (2001) Vitamin E: Too much or not enough? Am. J. Clin. Nutr., 73, 997-998.
47. Dreosti,I.E. (1998) Nutrition, cancer, and aging. Ann. NY Acad. Sci., 854, 371-377.
48. Weindruch,R., Albanes,D. and Kritchevsky,D. (1991) The role of calories and caloric restriction in carcinogenesis. Hematol. Oncol. Clin. North Am., 5, 79-89.
49. Yoshida,K., Inoue,T., Hirabayashi,Y., Nojima,K. and Sado,T. (1999) Calorie restriction and spontaneous hepatic tumors in C3H/He mice. J. Nutr. Health Aging, 3, 121-126.
50. Dunn,S.E., Kari,F.W., French,J., Leininger,J.R., Travlos,G., Wilson,R. and Barrett,J.C. (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res., 57, 4667-4672.
51. Steinbach,G., Kumar,S.P., Reddy,B.S., Lipkin,M. and Holt,P.R. (1993) Effects of caloric restriction and dietary fat on epithelial cell proliferation in rat colon. Cancer Res., 53, 2745-2749.
52. Rao,C.V., Hirose,Y., Indranie,C. and Reddy,B.S. (2001) Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res., 61, 1927-1933.
53. Kritchevsky,D. (1990) Nutrition and breast cancer. Cancer, 66, 1321-1325.
54. Valk,E.E. and Hornstra,G. (2000) Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: A review. Int. J. Vitam. Nutr. Res., 70, 31-42.
55. Sah,V.P., Attardi,L.D., Mulligan,G.J., Williams,B.O., Bronson,R.T. and Jacks,T. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet., 10, 175-180.
56. Anderson,L.M., Diwan,B.A., Fear,N.T. and Roman,E. (2000) Critical windows of exposure for children's health: Cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect., 108 (Suppl. 3), 573-594.
57. Vinson,R.K. and Hales,B.F. (2002) DNA repair during organogenesis. Mutat. Res., 509, 79-91.
58. Laposa,R.R., Chan,K., Wiley,M.J. and Wells,P.G. (1996) Enhanced phenytoin embryopathy in p53-deficient mice: Characterisation of embryonic p53 genotype and the p53, p21 and bax DNA damage response proteins. Fundam. Appl. Toxicol. (Suppl.: The Toxicologist), 30, 195, (No. 997, Abstract).
59. Winn,L.M. and Wells,P.G. (1995) Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: Evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol. Pharmacol., 48, 112-120.
60. Choi,J. and Donehower,L.A. (1999) p53 in embryonic development: maintaining a fine balance. Cell. Mol. Life Sci., 55, 38-47.
61. Schmid,P., Lorenz,A., Hameister,H. and Montenarh,M. (1991) Expression of p53 during mouse embryogenesis. Development, 113, 857-865.
62. Louis,J.M., McFarland,V.W., May,P. and Mora,P.T. (1988) The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim. Biophys. Acta., 950, 395-402.
63. Yamashita,N., Murata,M., Inoue,S., Burkitt,M.J., Milne,L. and Kawanishi,S. (1998) Alpha-tocopherol induces oxidative damage to DNA in the presence of copper (II) ions. Chem. Res. Toxicol., 11, 855-862.
64. Lee,S.H., Oe,T. and Blair,I.A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science, 292, 2083-2086.
65. Salas-Vidal,E., Lomeli,H., Castro-Obregon,S., Cuervo,R., Escalante-Alcalde,D. and Covarrubias,L. (1998) Reactive oxygen species participate in the control of mouse embryonic cell death. Exp. Cell Res., 238, 136-147.
66. Bauer,G. (2002) Signaling and proapoptotic functions of transformed cell-derived reactive oxygen species. Prostag. Leukot Essent. Fatty Acids, 66, 41-56.
67. Carmody,R.J. and Cotter,T.G. (2001) Signalling apoptosis: A radical approach. Redox Rep., 6, 77-90.
68. Haddad,J.J. (2002) Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal, 14, 879-897.
69. Haddad,J.J. (2002) Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines Cell Mol. Ther., 7, 1-14.
70. Schimmel,M. and Bauer,G. (2002) Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts. Oncogene, 21, 5886-5896.
71. Paolicchi,A., Dominici,S., Pieri,L., Maellaro,E. and Pompella,A. (2002) Glutathione catabolism as a signaling mechanism. Biochem. Pharmacol., 64, 1027-1035.
72. Parker,R.S., Sontag,T.J. and Swanson,J.E. (2000) Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem. Biophys. Res. Commun., 277, 531-534.
73. Sontag,T.J. and Parker,R.S. (2002) Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem., 277, 25290-25296.
74. Brigelius-Flohe,R. and Traber,M.G. (1999) Vitamin E: Function and metabolism. FASEB J., 13, 1145-1155.
75. Stahl,W., Graf,P., Brigelius-Flohe,R., Wechter,W. and Sies,H. (1999) Quantification of the alpha- and gamma-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman in human serum. Anal. Biochem., 275, 254-259.
76. Birringer,M., Drogan,D. and Brigelius-Flohe,R. (2001) Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation. Free Radic. Biol. Med., 31, 226-232.
77. Ikeda,S., Tohyama,T. and Yamashita,K. (2002) Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl- 2(2′-carboxyethyl -6-hydroxychroman excretion into urine of rats fed gamma-tocopherol. J. Nutr., 132, 961-966.
78. Landes,N., Pfluger,P., Kluth,D., Birringer,M., Ruhl,R., Bol,G.F., Glatt,H. and Brigelius-Flohe,R. (2003) Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol., 65, 269-273.
79. Lehmann,J.M., McKee,D.D., Watson,M.A., Willson,T.M., Moore,J.T. and Kliewer,S.A. (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest., 102, 1016-1023.
80. Kliewer,S.A., Goodwin,B. and Willson,T.M. (2002) The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism. Endocr. Rev., 23, 687-702.
81. Nagata,T., Takahashi,Y., Ishii,Y. et al. (2003) Profiling of genes differentially expressed between fetal liver and postnatal liver using high-density oligonucleotide DNA array. Int. J. Mol. Med., 11, 713-721.
82. Yang,H.Y., Lee,Q.P., Rettie,A.E. and Juchau,M.R. (1994) Functional cytochrome P4503A isoforms in human embryonic tissues: Expression during organogenesis. Mol. Pharmacol., 46, 922-928.
83. De Stefani,E., Brennan,P., Boffetta,P., Mendilaharsu,M., Deneo-Pellegrini,H., Ronco,A., Olivera,L. and Kasdorf,H. (2002) Diet and adenocarcinoma of the lung: A case-control study in Uruguay. Lung Cancer, 35, 43-51.
84. Malvy,D.J., Favier,A., Faure,H., Preziosi,P., Galan,P., Arnaud,J., Roussel,A.M., Briancon,S. and Hercberg,S. (2001) Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: Preliminary data of the SU.VI.MAX study. Cancer Detect. Prev, 25, 479-485.
85. Eichholzer,M., Stahelin,H.B., Ludin,E. and Bernasconi,F. (1999) Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective basel study. Prostate, 38, 189-198.
86. Sung,L., Greenberg,M.L., Koren,G., Tomlinson,G.A., Tong,A., Malkin,D. and Feldman,B.M. (2003) Vitamin E: The evidence for multiple roles in cancer. Nutr. Cancer, 46, 1-14.
87. Jacobs,E.J., Connell,C.J., McCullough,M.L., Chao,A., Jonas,C.R., Rodriguez,C., Calle,E.E. and Thun,M.J. (2002) Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort. Cancer Epidemiol. Biomarkers Prev., 11, 35-41.
88. Kristal,A.R., Stanford,J.L., Cohen,J.H., Wicklund,K. and Patterson,R.E. (1999) Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., 8, 887-892.
89. Albanes,D., Heinonen,O.P., Taylor,P.R. et al. (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention study: Effects of base-line characteristics and study compliance. J. Natl Cancer Inst., 88, 1560-1570.
90. Thompson,J.R., Gerald,P.F., Willoughby,M.L. and Armstrong,B.K. (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: A case-control study. Lancet, 358, 1935-1940.
91. Gale,K.B., Ford,A.M., Repp,R., Borkhardt,A., Keller,C., Eden,O.B. and Greaves,M.F. (1997) Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl Acad. Sci. USA, 94, 13950-13954.
92. Maia,A.T., Van Der Velden,V.H., Harrison,C.J., Szczepanski,T., Williams,M.D., Griffiths,M.J., Van Dongen,J.J. and Greaves,M.F. (2003) Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins. Leukemia, 17, 2202-2206.
93. Kempski,H., Mensa-Bonsu,K.A., Kearney,L., Jalali,G.R., Hann,I., Khurshid,M. and Greaves,M. (2003) Prenatal chromosomal diversification of leukemia in monozygotic twins. Genes Chromosomes Cancer, 37, 406-411.
94. Chen,C.S. and Wells,P.G. (2004) In utero origins of cancer: Maternal dietary vitamin E, fetal oxidative DNA damage and postnatal carcinogenesis in p53 knockout mice. Ann. NY Acad. Sci., 1031, 395-398.